| Value | ₹158.1 Cr |
|---|
BSE filing, BSE: 532154. Summary written from the filing by ALFA Finder's alert engine.
Johnson Pharmacare Ltd: key numbers
- Share price
- ₹0.37
- Market cap
- ₹20.35 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-55.73 Cr
- P/E (TTM)
- -0.4×Sector 45.2×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Johnson Pharmacare Ltd
All →Johnson Pharmacare Other Announcement
Johnson Pharmacare Limited has approved the shifting of its registered office within the local limits of Ahmedabad. This administrative change was approved at their board meeting.
Johnson Pharmacare Board Meeting Date
Johnson Pharmacare Limited has scheduled a board meeting on August 13, 2026, to consider and approve the standalone unaudited financial results for the quarter ending June 30, 2026.
Johnson Pharmacare Other Announcement
Johnson Pharmacare Ltd has submitted its quarterly shareholding pattern filing for the period ending June 30, 2026, as required by regulatory norms.
Johnson Pharmacare Management Change
Company Secretary Neha Srivastava resigned from the board effective June 11, 2026. The board acknowledges the change with no other material impact.
Johnson Pharmacare Other Announcement
Johnson Pharmacare filed its Annual Secretarial Compliance Report for FY2026. The report notes non-compliances regarding SDD maintenance and the appointment of internal auditors and a CFO.
Johnson Pharmacare Financial Results
Johnson Pharmacare reported audited financial results for the year ended March 31, 2026. The company faces a ₹21.40 Crore debt burden and auditor qualifications regarding internal controls.
- Value
- ₹21.40 Cr
Other financial results announcements
All →Glittek Granites Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Glittek Granites Ltd reported revenue from operations of ₹0.3 Cr and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.1 Cr · +92.9% YoY
STL Networks Q2 FY27 Results: Net Loss of ₹16.1 Cr, Loss Narrows
STL Networks Ltd reported revenue from operations of ₹270.1 Cr (+17.0% YoY) and a net loss of ₹16.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹16.1 Cr
RPG Life Sciences Q2 FY27 Results: Net Profit ₹28.2 Cr, Down 23.6% YoY
RPG Life Sciences Ltd reported revenue from operations of ₹211.6 Cr (+16.5% YoY) and net profit of ₹28.2 Cr (-23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹28.2 Cr · -23.6% YoY
Alldigi Tech Q2 FY27 Results: Net Profit ₹26.6 Cr, Up 51.1% YoY
Alldigi Tech Ltd reported revenue from operations of ₹153.3 Cr (+4.0% YoY) and net profit of ₹26.6 Cr (+51.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.6 Cr · +51.1% YoY
Krishna Defence and Allied Industries Q2 FY27 Results: Net Profit ₹1,532 Cr, Up 71.8% YoY
Krishna Defence and Allied Industries Ltd reported revenue from operations of ₹7,529 Cr (+55.7% YoY) and net profit of ₹1,532 Cr (+71.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,532 Cr · +71.8% YoY